NCT01440478View on ClinicalTrials.gov

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Healthy Subjects
Interventions
DRUG

LY2140023

Administered orally

DRUG

Ammonium chloride

Administered orally

DRUG

Sodium bicarbonate

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri, from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Leeds

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01440478 - The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects | Biotech Hunter | Biotech Hunter